BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Jeff Collins will participate in the US-India BioPharma Summit (theme: "Delivering Affordable Innovation through Cross-Border Partnerships") in Cambridge, MA
News | 06. 13. 2008
